Verapamil and Pancreatic Beta Cell Function in Pediatric Type 1 Diabetes-Reply.

Forlenza, Gregory P; Schamberger, Marcus S; Buckingham, Bruce A

Forlenza, Gregory P; Schamberger, Marcus S; Buckingham, Bruce A.

Affiliation

Forlenza GP; Barbara Davis Center, University of Colorado Anschutz Medical Campus, Aurora.
Schamberger MS; Division of Pediatric Cardiology, Indiana University School of Medicine, Indianapolis.
Buckingham BA; Division of Pediatric Endocrinology, Stanford University, Palo Alto, California.

JAMA ; 330(4): 380, 2023 07 25.

Article in En | MEDLINE | ID: mdl-37490087

Subject(s)

Calcium Channel Blockers; Diabetes Mellitus, Type 1; Insulin-Secreting Cells; Verapamil; Child; Humans; Diabetes Mellitus, Type 1/drug therapy; Insulin-Secreting Cells/drug effects; Verapamil/pharmacology; Verapamil/therapeutic use; Calcium Channel Blockers/pharmacology; Calcium Channel Blockers/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Calcium Channel Blockers / Verapamil / Diabetes Mellitus, Type 1 / Insulin-Secreting Cells Limits: Child / Humans Language: En Journal: JAMA Year: 2023 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google